Eli Lilly and Company
A Scientist at Lilly's BioTDR organization focuses on advancing AI-driven drug discovery through computational protein design, protein bioscience, and high-throughput experimentation. The role involves developing AI-orchestrated pipelines for biologic design and engineering, with an emphasis on scientific excellence and cross-functional collaboration.
Headquarters
Indianapolis, Indiana, United States
Company Size
10001+ employees
Founded
1876
Eli Lilly and Company is a global biopharmaceutical company headquartered in Indianapolis, Indiana. It discovers, develops, manufactures and commercializes prescription medicines across therapeutic areas including diabetes, oncology, immunology, neuroscience and pain, and has a longstanding history in insulin and other major drug discoveries. Lilly invests heavily in research and clinical development and partners with biotech, academic institutions, and industry collaborators to advance biologics, small molecules, and precision medicines. The company operates global manufacturing and commercial networks and provides patient-support programs to improve access to its therapies.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Eli Lilly and Company.
49% above the average for this role
Li Auto OTA Upgrade And Charging Use Test Investor Patience
1 week ago
Postdoctoral Fellow: Generative AI for Protein Engineering
Pfizer
Senior Specialist, Computational Protein Design
MSD
Scientist/Senior Scientist, Protein Sciences & Biologics Development
Aragen Life Sciences
ML Research Scientist, Co-Folding and Affinity
SandboxAQ
Sr Director, Protein Biochemistry and Lab Automation
Gilead Sciences
Sr Scientist -- Biologics Engineering, Protein Therapeutics
Gilead Sciences